Clinical trial
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
NCT03255057
Study timeline
Study start (actual)2018-02-18Date precision: day
Registry last updated2022-10-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Acute Exacerbation of COPDunresolved
Interventions
Sponsors & collaborators
Alung Technologieslead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1MinneapolisMinnesota, United States1JacksonvilleFlorida, United States1DenverColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03255057 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.